Month: April 2019

Retinal Physician – “Real-World” Outcomes of Anti-VEGF Therapy in Neovascular AMD in the United States

In our “real world” study of 49,485 “wet” AMD patient-eyes treated with anti-VEGF agents, visual acuity improved by only 1 letter at 1 year! Outcomes fall far short of randomized clinical trial results. New therapies are needed. Retinal Physician – “Real-World” Outcomes of Anti-VEGF Therapy […]